Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

Bimatoprost is safe but not effective for severe eyelash loss from alopecia areata, possibly helping those with less loss.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Cyclosporine A can help some people with severe alopecia areata regrow hair.

Systemic corticosteroids don't prevent severe alopecia areata from spreading or relapsing.

A woman's hair loss was initially mistaken for a common hair loss condition but was later found to be caused by breast cancer cells in her scalp.

The steroid solution can regrow hair but often causes skin issues and doesn't work long-term.

IGF-1 may affect hair growth and loss, but more research is needed to confirm effective and safe treatments.

Astressin-B can reverse and prevent hair loss in stressed mice.

Most hair loss in captive rhesus macaques is likely due to environmental and behavioral factors.

Vogt-Koyanagi syndrome often leads to partial or complete blindness and responds poorly to treatment.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Dupilumab can both heal and cause hair loss.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Personality traits and anxiety affect hair loss patients' quality of life.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Patients with alopecia areata might have a lower risk of stroke and possibly heart attack.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Quercetin effectively treated and prevented hair loss in mice.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

Steven Kossard classified lymphocyte-related hair loss into four patterns, each linked to different types of baldness.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

ODC1 gene mutations cause a neurodevelopmental disorder with large head size, hair loss, and facial abnormalities.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

New lipid nanoparticles show promise for delivering hair loss treatments but need improvement for better skin penetration.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.